The Widening Gender Gap in Marijuana Use Prevalence in the U.S. during a Period of Economic Change, 2002-2014.
To determine use prevalence for alternative and complementary medicines at the National Cancer Institute of Colombia.
The Indonesian government frequently cites statistics from its national narcotics board, which estimates illicit drug use prevalence to to be at 2.6% – equivalent to 4.5m people – and suggested as many as 50 drug-related deaths were occurring every day.
Increased instructional efforts concerning the clinical treatment of tobacco dependence are critical for achieving a nationwide reduction in tobacco use prevalence.
This study yielded an opioid use prevalence of 4.1%%.
There was no significant yearly variation in treatment use prevalence over 9 years.
Further, sensitivity analysis assuming an 8%% medication use prevalence for opioids, was conducted.
The closest evidence of opioid use prevalence that we identified was a Swedish study including chronic headache patients.
Researchers in two previous studies assessed whether doctors use prevalence beliefs based on their own experience in diagnosis.
Fourteen studies informed MOH for both triptans and ergots in countries where medication use prevalence estimates were also available for both.
Twelve studies informed MOH for both ergots and analgesics in countries where medication use prevalence estimates were also available for both.
